ClinicalTrials.gg
RecruitingNCT04748809Updated Nov 5, 2026

Effect of Anti-inflammatory Diet in Rheumatoid Arthritis

An interventional study of Diet 1 and Diet 2 in Rheumatoid Arthritis, sponsored by University of California, San Diego. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-05.

Sponsored by University of California, San Diego · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Nov 2020; still recruiting 6 years later.
Updated Nov 5, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
124
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 975 studies in Arthritis, Rheumatoid with a site in United States — 82 open to participants now, 121 under way, 7 of them phase 3. Arthritis, Rheumatoid · United States.

Planned enrollment
374th of 771
124 · median 120
Started
2020
with 30 others
No phase
164 of 975
18 open now
Primary completion
2027-02
later than 42 of 120 live
Registered
821st of 975
by date

Among the 975 studies in Arthritis, Rheumatoid with a site in United States, this one is the 374th largest by planned enrollment of the 771 interventional ones that give a count, is one of 31 that started in 2020, is one of 164 with no phase, reaches primary completion later than 42 of the 120 other live ones, and was the 821st registered.

Arthritis, Rheumatoid

3,339 studies on the registry are indexed under Arthritis, Rheumatoid; 446 are open to participants now.

Browse Arthritis, Rheumatoid studies →

Open to participants now

82 of the 975 studies in Arthritis, Rheumatoid with a site in United States are open now. Recruiting first, the newest first:

77 more — sign in →

All 82 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 293 Arthritis, Rheumatoid studies recruiting now, 151 (52%) set no upper age limit and 109 (37%) stop at 75 or younger; 15 take children under 18; 36 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 975 studies in Arthritis, Rheumatoid with a site in United States, or all of them as a file.
02

Study summary

In a previous exploratory study, the investigators observed an effect on disease activity outcomes of anti-inflammatory diet. The investigators also observed change in microbiome and circulating metabolites. The current study will determine whether or not the addition of anti-inflammatory diet improves the clinical outcomes in participants with rheumatoid arthritis, and the role of microbiome and circulating metabolites.

03

Conditions studied

  • Rheumatoid Arthritis
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with low or moderate disease activity (defined as Clinical Disease Activity Index ≤ 22) and without changes in disease activity or therapy during the previous 3 months, who are interested in dietary intervention, and are able to provide consent and attend to follow up visits.

Exclusion criteria

Exclusion Criteria:

  • Pregnancy or lactating. Patients that will become pregnant during the study will be remove from the study.
  • Food allergies
  • Subjects with significant other comorbidities and /or medication use which in physician's clinical judgment might difficult the interpretation of the results
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
124 participants (estimated)

Study arms

  • Active comparator
    Arm_1

    Anti-inflammatory diet 1

    Other: Diet 1

  • Experimental
    Arm_2

    Anti-Inflammatory diet 2

    Other: Diet 2

Interventions

  • OtherDiet 1

    Dietary intervention

    Also known as: anti-inflammatory diet 1

  • OtherDiet 2

    Dietary intervention

    Also known as: anti-inflammatory diet 2

06

What researchers measure

Primary outcomes

  1. Decrease of more than 5 points in Clinical Disease Activity Index

    Time frame: 3 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2020 (actual). Primary completion is estimated for Feb 2027, 75 months after the start.

Of 293 non-industry interventional studies with no phase under Arthritis, Rheumatoid, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 39. This study's planned 75 months is above that.

Counting every sponsor, half of 349 studies reached it within 27 months; a quarter within 13 and three quarters within 47.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 5, 2026: primary completion Feb 2026 → Feb 2027 and completion Mar 2026 → Mar 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 26, 2021
First posted
Feb 10, 2021
StartActual
Nov 1, 2020
Primary completionEst.
Feb 1, 2027was Feb 2026
CompletionEst.
Mar 1, 2027was Mar 2026
Last update
Nov 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Feb 1, 2026→Feb 1, 2027
Nov 5, 2026
Study completion
Mar 1, 2026→Mar 1, 2027
Nov 5, 2026
Show all 1 update
  1. Nov 5, 2026
    Primary completion Feb 1, 2026→Feb 1, 2027
    Study completion Mar 1, 2026→Mar 1, 2027

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04748809
Responsible party
Monica Guma (Associate Professor of Medicine, University of California, San Diego) — Principal investigator
First posted
Feb 10, 2021
Start date
Nov 1, 2020
Primary completion
Feb 1, 2027 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Nov 5, 2026

Study contacts

Monica Guma, MD, PhD
Contact
mguma@health.ucsd.edu
8588226523

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion